Skip to content

A cohort study of cerebral small vessel disease based on human brain tissue samples

A cohort study of cerebral small vessel disease based on human brain tissue samples

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053863
Enrollment
Unknown
Registered
2021-12-01
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease

Interventions

white matter hyperintensity group:None
normal control group:None

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-80 years; 2. Non-hereditary cerebral small vessel disease and/or intracranial mass patients with white matter hyperintensity on imaging.

Exclusion criteria

Exclusion criteria: 1. Those who do have autoimmune diseases (such as: autoimmune encephalitis, systemic lupus erythematosus, etc.); 2. There are malignant tumors in other parts of the body and are in the stage of chemotherapy, radiation therapy and biological targeted therapy; 3. Diffuse intracerebral lesions and high degree of malignancy; 4. The lesion is close to the cerebral cortex or invades the cerebral cortex; 5. Those with genetic diseases and brain developmental malformations; 6. Those who have an infectious disease or enter an epidemic area; 7. Other researchers believe that it is not suitable to participate in this research.

Design outcomes

Primary

MeasureTime frame
Differences in protein expression;

Countries

China

Contacts

Public ContactWang Yilong

Beijing Tiantan Hospital, Capital Medical University

yilong528@gmail.com+86 13911666571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026